Isolated 3-Methylcrotonyl CoA Carboxylase Deficiency Detected by Newborn Screening Program Using Tandem Mass Spectrometry.
- Author:
Ju Young KWAK
1
;
Jun Young PARK
;
Kyung A NAM
;
Sang Hi SON
;
Son Sang SEO
Author Information
1. Department of Pediatrics, Il Sin Christian Hospital, Pusan, Korea. sss@ilsin.or.kr
- Publication Type:Case Report
- Keywords:
3-Methylcrotonyl CoA carboxylase;
Tandem mass spectrometry
- MeSH:
Birth Weight;
Carnitine;
Female;
Growth and Development;
Humans;
Incidence;
Infant, Newborn*;
Infant, Premature;
Leucine;
Mass Screening*;
Oligohydramnios;
Pre-Eclampsia;
Pregnancy;
Tandem Mass Spectrometry*
- From:Korean Journal of Pediatrics
2005;48(5):561-564
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Isolated deficiency of 3-methylcrotonyl CoA carboxylase is a rare disorder of the catabolic pathway for leucine and many patients have mild symptoms or no symptom. However, the introduction of tandem mass spectrometry in newborn screening has revealed an unexpectedly high incidence of this disorder. We report an asymptomatic premature infant with isolated 3-methylcrotonyl CoA carboxylase deficiency detected by newborn screening program using tandem mass spectrometry. She was born at preterm, 36 weeks of gestation and her birth weight was 1,912 gm. She was delivered by Cesarian section due to maternal preeclampsia and oligohydramnios. An elevation of 3-hydroxyisovalerylcarnitine in a blood sample obtained at Seven days was detected by tandem mass screening. Massively elevated excretion of 3-hydroxyisovalerate and 3-methylcrotonylglycine was detected in the urine collected at 15 days. L-carnitine(100 mg/kg/day) was administrated orally to correct sencondary carnitine deficiency. Carnitine is conjugated with metabolites, to decrease the potential toxic effects. She is asymptomatic to date, and her growth and development are within normal limits.
